Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1370712
PUBLISHER: BCC Research | PRODUCT CODE: 1370712
Nanomaterials in Personalized Medicine: Global Markets
PUBLISHED:
PAGES: 226 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.
Proteins market for nanomaterials in personalized medicine is expected to increase from $112.8 billion in 2023 to $203.2 billion by the end of 2028, with a CAGR of 12.5% during the forecast period of 2023-2028.
Monoclonal antibodies market for nanomaterials in personalized medicine is expected to increase from $78.0 billion in 2023 to $136.4 billion by the end of 2028, with a CAGR of 11.8% during the forecast period of 2023-2028.
Report Scope:
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.
Report Includes:
- 27 data tables and 50 additional tables
- An overview of the global market for nanomaterials in personalized medicine
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussions of the current and future market potential, and quantification of the market by product type and region
- Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
- Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
- Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
- Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
- Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
- Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
- Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma
Product Code: HLC144C
Table of Contents
Chapter 1 Introduction
- Overview of Nanotheranostics
- Polymeric Nanomaterials
- Magnetic Nanomaterials
- Silica-Based Nanomaterials
- Carbon Nanomaterials
- Composite Nanomaterials
- Biologic Nanomaterials: Antibody, Proteins and DNA
- Carbon Nanotubes
- Other Nanomaterials
- Multifunctional Nanomaterials
- Drug Delivery
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in this Update?
- Methodology
- Information Sources
- Geographic Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Insights
Chapter 3 Market Overview
- Market Overview
- Theranostics and Personalized Medicines Overview
- Nanoparticles
- Passive Targeting
- Active Targeting
- Nanotechnology Overview
- Size Definition
- Shape
- Surface Area
- Nanotheranostic Drug Delivery
- In Vivo Drug-Release Studies
- Drug Efficacy
- Future Perspectives
Chapter 4 Nanodevices and Nanomaterials in Diagnostics
- Overview
- Molecular Recognition in Diagnosis
- Nanopatterned Devices
- Particles
- Carbon Nanotubes
- Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
- Cancer Photothermal Therapy
- Carbon Nanotubes for Other Therapeutic Applications
- Fullerene C60
- C60 Toxicity
- Uptake and Biodistribution
- Antioxidant Properties
- Endohedrals
- Magnetic Resonance Imaging
- Radionuclides
- Photodynamic Therapy
- DNA Photocleavage
- Cancer
- Enzymes, Viruses, and Bacteria Inhibition
- Drug and Gene Delivery
- Magnetic Nanoparticles
- Hyperthermia
- Magnetic Separation
- Imaging and Delivery
- Brain Tumor Delivery
- Prostate Cancer
- Bladder Tumors
- Quantum Dots
- Aptamer-Conjugated Nanoparticles
- Nanoparticle-Based Bio-Bar Codes
- Multiplex Dendrimers
- Surface Enhanced Raman Spectroscopy
- Diagnostic and Medical Device Industry
- Multifunctional Nanoparticles
- Polymeric Nanoparticles in Cancer Therapy
- Polymeric-Based Imaging Probes for Cancer Imaging
- Quantum Dots in Cancer Imaging and Therapy
- Quantum Dots in Photodynamic Therapy and Imaging
- Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
- Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
- Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
- Gold Nanoparticles for Photothermal Therapy
- Gold Nanoshells
- Gold Nanorods
- Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
- Conclusion and Future Trends
Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices
- Infections Associated with Medical Devices and Their Treatments
- Catheter-Associated Infections
- Soft-Tissue-Implant-Associated Infections
- Biofilm Formation
- Common Methods for Preventing and Treating Medical Device-Associated Infections
- Nanomaterials in Medical Applications
- Nanomaterials in Personalized Medicine
- Antimicrobial Nanomaterials
- Silver Nanoparticles
- Zinc Oxide
- Iron and Iron-Oxide Nanoparticles
- Titanium Oxide
- Carbon Nanotubes and Fullerenes
- Chitosan
- Cytotoxicity Consideration
Chapter 6 Biomedical Nanoparticle Products
- Introduction
- Contract Manufacturing Organizations
- Information Technology
- Nanoparticle Drug Delivery Systems and Products
- Nanoparticle Drug Delivery Systems
- Company Pipelines for Nanoparticle Drug Delivery
Chapter 7 Therapeutic and Diagnostic Companion Kits
- Introduction
Chapter 8 Market Dynamics
- Market Drivers
- Rising Prevalence of Chronic Diseases Globally
- Rising Cancer Cases Globally
- Cancer Mortality
- Increasing Number of Diabetes Cases Worldwide
- Rising Worldwide Cases of Hypercholesterolemia
- Other major drivers in the personalized medicine market are:
- Market Restraints
- Challenges with Personalized Medicine
- Market Opportunities
- Nanodrug Delivery for the Treatment of Neurological Disorders
- Increasing Government Investment in Healthcare Sectors
- Rising Healthcare Costs
- Consumer Expectations
Chapter 9 Regulatory Landscape
- Overview
- Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
- Regulatory Issues in Nanotechnology
- Nanomedicines in the Pharmaceutical Market
- Market Access and Pharmacoeconomics
Chapter 10 Impact of COVID-19 on the Market
- Overview
- Structure of COVID-19 and Penetration
- COVID-19 Crisis
- Impact of COVID-19 on Nanomaterials in Personalized Medicine
- Novel Coronavirus Relying on Various Approaches
- Challenges in Vaccine Disruptions
- Components and Methods in the Design of a Vaccine
- Antigens
- Adjuvants
- Nanoparticles/Nanocarriers
- Devices
- Next-Generation Vaccines Enabled Through Advances in Nanotechnology
- Conclusions Regarding Use of Nanotechnology to Combat COVID-19
- COVID-19 Measures
Chapter 11 Market Breakdown by Product Type
- Market Overview
- Proteins
- Monoclonal Antibodies (mAbs)
- Monoclonal Antibody Therapy
- Mechanism
- Nanocrystals
- Nanocrystals Fabrication
- Liposomes
- Liposome Classification and Preparation
- Sonication
- Extrusion
- Freeze-Thawed Liposomes
- Solvent Dispersion Method
- Detergent-Removal Method
- Stealth Liposome
- Antibody-Liposome Conjugate
- Liposome Application in Medicine and Pharmacology
- Liposomes in Parasite Diseases and Infections
- Liposomes in Anticancer Therapies
- In Vitro Optical Imaging
- Gold Nanocarrier
- Hyperthermia
- Contrast Enhancers
- Radiotherapy
- Quantum Dots as Nanocarriers
- Photophysical Properties, Drug-Delivery and Drug-Release Sensing
- Visualizing Intracellular Uptake In Vitro
- Nanocarrier Biodistribution In Vivo
- Short Interfering RNA and DNA delivery
Chapter 12 Market Breakdown by Region
- Overview
- North America
- U.S. Market Size and Forecast
- Canada Market Size and Forecast
- Europe
- Germany Market Size and Forecast
- U.K. Market Size and Forecast
- France Market Size and Forecast
- Italy Market Size and Forecast
- Spain Market Size and Forecast
- Rest of European Market Size and Forecast
- Asia-Pacific
- China Market Size and Forecast
- Japan Market Size and Forecast
- India Market Size and Forecast
- South Korea Market Size and Forecast
- Rest of Asia-Pacific Market Size and Forecast
- Rest of the World
- South America Market Size and Forecast
- Middle East and Africa Market Size and Forecast
Chapter 13 ESG Development
- Introduction to ESG
- Environmental
- Social
- Government
- The Sustainability of Major Companies in the Industry
- Pharma End User Sustainability in the Industry
- Case Study
- Concluding Remarks from BCC
Chapter 14 Emerging Technologies
- Overview
- Current Market Trends
- Emerging Technologies
- Biomarkers
- Deep Phenotyping Technologies
- Digital Precision Medicine
- Genetics
- Health Information Technology
Chapter 15 Patents and Pipeline Analysis
- Overview
- Patent Analysis
- Pipeline Analysis
Chapter 16 M&A Outlook
- M&A Analysis
- Major Strategic Alliances
Chapter 17 Competitive Landscape
- Overview
- Distribution of Nanobiotechnology and Nanomedicine Companies
- Company Share Analysis
Chapter 18 Company Profiles
- BRISTOL-MYERS SQUIBB
- CAMURUS AB
- CYTIMMUNE SCIENCES
- EISAI
- GILEAD SCIENCES INC.
- IPSEN PHARMA
Chapter 19 Appendix: Acronyms
Product Code: HLC144C
List of Tables
- Summary Table : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table A : Types of Nanomaterials
Table B : Major Nanomaterial Applications in Personalized Medicine
- Table 1 : Therapies with Diagnostic Companion Kits
- Table 2 : Nanoparticle Systems Approved for Drug Delivery
- Table 3 : Imaging Modalities Used in Theranostics Nanodevices
- Table 4 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
- Table 5 : Major Players in Nanoparticle Drug Development and Formulation Market
- Table 6 : Nanoparticles Used in Drug Delivery Systems
- Table 7 : List of Marketed Products Used in Different Nanotechnology-Based Techniques
- Table 8 : Major Companies in the Market for Nanoparticle Drug Development and Formulation
- Table 9 : Company Pipelines for Cardiovascular Nanoparticle Drugs
- Table 10 : Company Pipelines for CNS Disease Nanoparticle Drugs
- Table 11 : Company Pipelines for GI Disease Nanoparticle Drugs
- Table 12 : Company Pipelines for Infectious Disease Nanoparticle Drugs
- Table 13 : Company Pipelines for Cancer Nanoparticle Drugs
- Table 14 : Company Pipelines for Ophthalmic Nanoparticle Drugs
- Table 15 : Company Pipelines for Autoimmune Disease Nanoparticle Drugs
- Table 16 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
- Table 17 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
- Table 18 : Global Deaths, by Various Cancer Types, Through 2030
- Table 19 : Global Death Share, by Various Cancer Types, 2021
- Table 20 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
- Table 21 : Cases of Diabetes Worldwide, by Type, 2019
- Table 22 : Global Prevalence of Diabetes, by Type, Through 2040
- Table 23 : Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
- Table 24 : Global Incidence and Prevalence of all Stroke Types, 2019
- Table 25 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
- Table 26 : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
- Table 27 : Products of Non-monoclonal Antibody Proteins
- Table 28 : Global Market for Proteins in Personalized Medicine, by Region, Through 2028
- Table 29 : Major Companies in the Market for Monoclonal Antibodies
- Table 30 : Indications of Monoclonal Antibody Products
- Table 31 : Global Market for Monoclonal Antibodies in Personalized Medicine, by Region, Through 2028
- Table 32 : Properties of Nanocrystals
- Table 33 : Nanocrystal Drug Features
- Table 34 : Nanocrystal Fabrication Methods
- Table 35 : Nanocrystal Drugs Currently on the Market
- Table 36 : Global Market for Nanocrystals in Personalized Medicine, by Region, Through 2028
- Table 37 : Liposome Advantages
- Table 38 : Liposome-Based Drugs
- Table 39 : Major Companies in the Liposomes Market
- Table 40 : Global Market for Liposomes in Personalized Medicine, by Region, Through 2028
- Table 41 : Global Market for Gold Nanoparticles in Personalized Medicine, Through 2028
- Table 42 : Global Market for Quantum Dots in Personalized Medicine, Through 2028
- Table 43 : Global Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
- Table 44 : Diabetes Estimates in North America, by Country, 2000-2045
- Table 45 : Influenza Disease Burden in U.S., by Age Group, 2019 and 2020 Influenza Season
- Table 46 : North America Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
- Table 47 : Diabetes Estimates in Europe, by Country, 2000-2045
- Table 48 : European Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
- Table 49 : Tuberculosis Burden of Asian Countries, by Country, 2019
- Table 50 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
- Table 51 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
- Table 52 : Diabetes Estimates in the RoW, by Country, 2000-2045
- Table 53 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
- Table 54 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
- Table 55 : Key Focus Areas in ESG Metrics
- Table 56 : ESG Rankings for Select Nanomaterials Personalized Medicine Companies, 2023
- Table 57 : Examples of Nanomaterials Used in Theranostics
- Table 58 : Global Patents on Nanotechnologies, by Country, 2017-2020
- Table 59 : Number of Patents, by Technology, 2001-2021*
- Table 60 : Protein Drugs
- Table 61 : Nanoparticle Systems Approved for Drug Delivery
- Table 62 : Major Strategic Alliances, 2018-2023
- Table 63 : Major Players in the Nanoparticles Drug Field
- Table 64 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
- Table 65 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
- Table 66 : Bristol-Myers Squibb: Key Developments, 2019
- Table 67 : Camurus AB: Financial Performance, 2021 and 2022
- Table 68 : Camurus AB: Key Developments, 2019
- Table 69 : Cytimmune Sciences: News, 2021
- Table 70 : Eisai: Financial Performance, 2021 and 2022
- Table 71 : Eisai: News, 2021
- Table 72 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
- Table 73 : Ipsen Pharma: Financial performance, 2021 and 2022
- Table 74 : Acronyms Used in This Report
List of Figures
Figure A : Types of Nanomedicine Composed of Different Types of Materials
- Summary Figure : Global Market Shares of Nanomaterials in Personalized Medicine, by Product Type, 2022
- Figure 1 : Types of Nanomedicines Composed of Different Types of Materials
- Figure 2 : Nanoparticles Used in Personalized Medicine
- Figure 3 : Nanotechnology Used in Personalized Medicine
- Figure 4 : Shares of New Cancer Cases, Women, 2020
- Figure 5 : Shares of New Cancer Cases, Men, 2020
- Figure 6 : Global Prevalence of Breast Cancer, by Country/Region, 2015-2025
- Figure 7 : Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
- Figure 8 : Global Deaths, by Various Cancer Types, 2000-2030
- Figure 9 : Global Death Share, by Various Cancer Types, 2021
- Figure 10 : Cases of Diabetes Worldwide, by Type, 2019
- Figure 11 : Global Prevalence of Diabetes, by Type, 2018 and 2040
- Figure 12 : Protein Nanoparticle Fabrication and Performance Factors
- Figure 13 : Global Market for Proteins in Personalized Medicine, 2020-2028
- Figure 14 : Global Market for Monoclonal Antibodies in Personalized Medicine, 2020-2028
- Figure 15 : Global Market for Nanocrystals in Personalized Medicine, 2020-2028
- Figure 16 : Application of Liposomes in the Drug Delivery Arena
- Figure 17 : Global Market for Liposomes in Personalized Medicine, 2020-2028
- Figure 18 : Global Market for Gold Nanoparticles in Personalized Medicine, 2020-2028
- Figure 19 : Global Market for Quantum Dots in Personalized Medicine, 2020-2028
- Figure 20 : Global Market Shares of Nanomaterials in Personalized Medicine, by Region, 2022
- Figure 21 : North America Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
- Figure 22 : Cancer Diagnosis Share in Europe, by Gender, 2020
- Figure 23 : European Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
- Figure 24 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
- Figure 25 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, 2020-2028
- Figure 26 : How a Strong ESG Proposition Benefits Businesses
- Figure 27 : ESG-Adoption Level Across All the Industries, 2021 and 2022
- Figure 28 : The Ten Business Sustainability Trends Identified for 2022
- Figure 29 : Key Sustainable Practices Being Implemented in Research Laboratories
- Figure 30 : Emerging Technologies in the Nanomaterials in Personalized Medicine Market
- Figure 31 : Global Market Shares of Nanoparticles in Personalized Medicine, by Company, 2022
- Figure 32 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
- Figure 33 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2022
- Figure 34 : Camurus AB: Financial Performance, 2021 and 2022
- Figure 35 : Camurus AB: Revenue Share, by Country/Region, 2022
- Figure 36 : Eisai: Financial Performance, 2021 and 2022
- Figure 37 : Eisai: Revenue Share, by Country/Region, 2022
- Figure 38 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
- Figure 39 : Gilead Sciences Inc.: Revenue Share, by Country/Region, 2022
- Figure 40 : Ipsen Pharma: Financial Performance, 2021 and 2022
- Figure 41 : Ipsen Pharma: Revenue Share, by Segment, 2022
- Figure 42 : Ipsen Pharma: Revenue Share, by Country/Region, 2022
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.